Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
CABLIVI Trockensub 10 mg c Solv Durchstf
Drug
Cablivi, poudre et solvent pour solution injectable
Behandlung einer Episode von erworbener thrombotisch-thrombozytopenischer Purpura (aTTP)
06.03.0. – anticoagulants
HAM – Human medicine
PULP – Powder and solvent for parenteral use
BT – biological medicines
B – Dispensed on prescription by a physician or veterinarian (B)
Z – approved
10/1/2019
9/30/2024
Dosage strength
Cablivi 10mg, poudre et solvent pour solution injectable
Traitement d'un épisode de purpura thrombotique thrombocytopénique acquis (PTTa)
01
Z – approved
Package
7680667920014
No information made available
A/R – Authorised / referenced
1 set
001
Z – approved
Declaration
Component Freeze-dried preparation
10 mg caplacizumabum
acidum citricum
natrii citras dihydricus
1 mg natrium
saccharum
polysorbatum 80
natrii citras dihydricus
1 mg natrium
saccharum
polysorbatum 80
Component Solvent
aqua ad iniectabile
Authorisation holder
7601001002340
Sanofi-Aventis (Suisse) SA
route de Montfleury 3
1214 Vernier (GE)
route de Montfleury 3
1214 Vernier (GE)
Date of revision of the text
9/1/2023
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.